Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter


1

Longer-Lasting Botox Rival Nears US Approval

Reloxin's makers claim it lasts longer

Share

(Newser) – After a 7-year run as the only show in town, Botox could soon face some competition. Awaiting FDA approval, Reloxin—the US version of a French product called Dysport—is being marketed as a quicker and longer-lasting treatment for botulinum toxin fans. But doctors themselves are confused about what differences, if any, exist between the wrinkle-smoothers, the New York Times reports.

Some docs use the drugs for different wrinkles, but see little disparity. Others purport that, with a practiced hand, they need less of Dysport to produce the same results as Botox. With each dose at more than $250, that could be a hefty savings. But Dysport novices, as many US doctors will be, may fumble until they figure out the proper dosages.

Docs can save money by using Reloxin, some say, because it requires a smaller dosage than Botox for the same results.
Docs can save money by using Reloxin, some say, because it requires a smaller dosage than Botox for the same results.   (AP Photo)
Reloxin will be made of butolinum toxin, just like Botox, but is reputed to have a longer-lasting result.
Reloxin will be made of butolinum toxin, just like Botox, but is reputed to have a longer-lasting result.   (AP Photo)
A dermatologist with a practice in both continents says Dysport lasts longer and looks more natural.
A dermatologist with a practice in both continents says Dysport lasts longer and looks more natural.   (PRNewsFoto)
« Prev« Prev | Next »Next » Slideshow

I don't like that Dr. Spock look.
- Dr. Nick Lowe, who uses Dysport for a more natural result

« Prev« Prev | Next »Next » Slideshow
OFF THE GRID
11.20.09
The Health-Care Wars Have Just Begun
11.19.09
Sarah Palin Deserves Some More Attention
1 comment
VIEWING:
 
SPH
Apr 2, 09 12:54 PM CDT
I hate it when they "fumble until they figure out the proper dosages"..... Reply
Vote up! Vote down!
0
LEAVE A
COMMENT Comment Policy
Facebook ConnectPost this comment to Facebook?

After connecting you will have the option to post your comment on your Facebook profile.

 

Related Newser Stories

101 Stories

(Newser) - You might suspect a sushi restaurant that doesn’t specify what sort of tuna you’re eating of trying to pawn off an inferior species. Not so. Researchers using novel DNA barcoding technology found that though nearly a third of tuna sold in 31 US restaurants was the prized—and... More »

MORE ABOUT:
endangered species • FDA • restaurant • delicacy • seafood • dining • sushi • Food and Drug Administration • overfishing • bluefin tuna • truth in advertising • DNA barcoding

FDA Demands Safety Data on Energy Drinks With Alcohol

Companies have 30 days to comply

Nov 13, 09 6:20 PM CST
(Newser) - The FDA has taken action against companies that make alcoholic energy drinks, giving the firms 30 days to provide evidence to support their claim that caffeine and booze are a safe combination. A group of concerned scientists have said there is no evidence to support the claim that the drinks... More »

MORE ABOUT:
FDA • alcohol • caffeine • energy drink • Smirnoff • Diageo • MillerCoors • Anheuser-Busch • Food and Drug Administration • Constellation Brands • Wide Eye

SHE WANTS BUTT IMPLANTS, TOO


 Winehouse 
 Addicted...to 
 Ping-Pong 

Amy Winehouse stays in to play table tennis, considers a butt job

Nov 11, 09 10:42 AM CST
(Newser) - Amy Winehouse has a new addiction. What vice is it this time: Cocaine? Her ex-husband? Nope. It’s her new ping-pong table. “She barely leaves the house,” a source tells the Mirror . In equally ridiculous Winehouse news, the recently-breast-enhanced singer is now pining for bigger boobs—and considering... More »

MORE ABOUT:
entertainment • plastic surgery • celebrity • cosmetic surgery • Amy Winehouse • table tennis • ping-pong

101 Stories


It's all the same: Chicago doc
RealSelf.com

Botox holds 83% of market share
Bloomberg


Science & Health  •  Business  •  US 
TwitterFollow @NewserScience on Twitter

 
cosmetic surgery • Botox • pharmaceutical • Food and Drug Administration • Dysport • Reloxin

from our news partners